Second Annual Conference on the State of Science on Development and Use of NAMs for Chemical Safety Testing
- Conference Background
- Conference Agenda, Presentations and Recordings
- Logistical Details
- Additional links
Conference Background
EPA’s Office of Chemical Safety and Pollution Prevention (OCSPP) and Office of Research and Development (ORD) hosted the First Annual Conference on the State of the Science on Development and Use of New Approach Methods (NAMs) for Chemical Safety Testing on December 10, 2019. The Second Annual NAMs conference was held Oct. 19-20, 2020.
These annual conferences are one of EPA’s commitments as set forth in the "Directive to Prioritize Efforts to Reduce Animal Testing" memorandum Administrator Andrew Wheeler signed on September 10, 2019 calling for the Agency to reduce its use of mammalian studies.
Agenda topics
- Implementation of Animal Testing Reduction at EPA
- State of the Science in Development of NAMs (Case Studies)
- Addressing Current Limitations in NAMs
- Developing Scientific Confidence in NAMs
Logistical Details
Date
The conference was held virtually October 19-20, 2020
Conference Agenda, Presentations, Recordings and Materials
2020 Agenda
Conference Summary
EPA Administrator Wheeler's Opening RemarksExit
Recording of Day OneExit
Recording of Day TwoExit
Transcript of Administrator Wheeler's Opening remarks
Presentation |
Presenter |
Affiliation |
---|---|---|
Russell Thomas |
EPA |
|
Progress on Implementing the TSCA Alternatives Strategic Plan |
Gino Scarano |
EPA |
Andreas Bender |
Cambridge |
|
Transcriptome-Based Derivation of an In Vivo POD: Current and Future Utility |
Kamin Johnson |
Corteva |
“Fit for Purpose” for Organotypic Models in Environmental Health Protection |
Ivan Rusyn |
Texas A&M |
Retrofitting an Estrogen Receptor Transactivation Assay with Metabolic Competence |
Chad Deisenroth |
EPA |
In Vitro Disposition of Tox21 Chemicals: Initial Results and Next Steps |
David Crizer |
NTP6 |
Clemens Wittwehr |
JRC |
|
Case Study #1: Integration of NAM Data for Evaluating Potential Developmental Neurotoxicity |
Monique Perron |
EPA |
Case Study #2: Integration of NAM Data in a Next Generation Risk Assessment for Cosmetic Ingredients |
Andrew White |
Unilever |
Todd Stedeford |
EPA |
Additional Links
- Alternative Test Methods and Strategies to Reduce Vertebrate Animal Testing
- Efforts to Reduce Animal Testing at EPA
- Directive to Prioritize Efforts to Reduce Animal Testing
- First Annual Conference on the State of the Science on Development and Use of New Approach Methods (NAMs) for Chemical Safety Testing